Trikafta is a combination medication containing elexacaftor, tezacaftor, and ivacaftor. It's used to treat cystic fibrosis (CF) in people 2 years and older. It's for those with specific gene mutations that cause problems with the CFTR protein. Trikafta works as a CFTR modulator to relieve some CF symptoms of CF. It comes as tablets and packets of oral granules for young children that are taken by mouth twice a day. Side effects include headache, stomach pain, and upper respiratory tract infections. As of mid-2025, there's no generic version available.
Cystic fibrosis (CF) in people 2 years and older with specific mutations
Trikafta is a combination of three medications. Together, they work as CFTR modulators. They act directly on a protein in the body called cystic fibrosis transmembrane conductance regulator (CFTR). This helps the CFTR protein work better.
This is important for people with cystic fibrosis (CF) because they have genetic mutations that make the CFTR protein not work right. This causes problems in the body, like a buildup of thick, sticky mucus in the lungs.
By helping CFTR proteins work properly, Trikafta helps relieve some symptoms of CF.
Note: There are many different gene mutations that can cause CF. Trikafta can only treat CF that's caused by specific mutations.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Has three CF medications in one, so more convenient to take
Packaged as weekly "wallets" that tell you which tablet or packet you need to take and when
Okay for children as young as 2 to take
Taken twice a day
Need to take with high-fat meals, like whole milk, yogurt, or cheese
Risk of liver damage
In general, you have a morning dose and an evening dose of Trikafta. Take them about 12 hours apart. Set a reminder on your phone to help you remember when to take your medication. Taking Trikafta on time helps it work the best it can for you.
Take Trikafta with a high-fat meal or snack, like avocado, eggs, or cheese. These types of foods help your body absorb the medication better.
Avoid foods or drinks with grapefruit while taking Trikafta. Grapefruit can raise the Trikafta levels in your body and raise your risk of side effects.
For the Trikafta tablets: Swallow the tablets whole. Don't chew, cut, or crush them.
For the Trikafta oral granule packets: Take the medication right before or after eating a high-fat meal or snack. Mix all the granules from the packet with 1 teaspoon of room-temperature soft food or liquid. You can use things like yogurt, applesauce, water, milk, or juice. Once mixed, give all of the medication within 1 hour.
Talk to your CF specialist and pharmacist before starting, stopping, or changing any medications while taking Trikafta. Be sure to include over-the-counter medications and supplements. Trikafta can interact with some medications and change how well they work and how safe they are. Your care team can help make sure all your medications are safe to take together.
What to do if you miss a dose of Trikafta:
If it's been 6 hours or less since you missed your morning or evening dose, take your usual dose as soon as possible. Afterwards, follow your dosing schedule as usual.
If it's been more than 6 hours since you missed your morning dose, take your usual morning dose as soon as possible. But don't take your evening dose. Continue with your usual dosing schedule the next day.
If it's been more than 6 hours since you missed your evening dose, don't take the medication to make up for it. Just wait until the next day to take your usual scheduled morning dose at the usual time.
Don't take the morning and evening doses at the same time to make up for any missed doses.
Trikafta can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: History of liver problems
Trikafta can sometimes cause higher liver enzyme levels. This can be a sign of liver damage. In some cases, liver damage can be serious and potentially life-threatening. Liver damage has happened within the first month and up to a year and a half after starting Trikafta.
Before starting Trikafta, tell your CF specialist if you have a history of liver problems. It's usually not recommended if you have moderate or severe liver problems. Your CF specialist will help you understand the risks and benefits. They'll help you decide if you should start Trikafta or not.
Your CF specialist will check your liver with blood tests before you start Trikafta. Then, you'll need these blood tests every month for the first 6 months, then every 3 months for the next year. After that, you'll need to get tested at least every year. If you have a history of liver problems, you might need blood tests more often.
If your blood tests show liver problems or if you have signs of liver damage, you'll need to stop Trikafta until you feel better. Watch for signs like stomach pain, dark urine, pale stools, or yellow skin or eyes. If this happens, get medical help right away.
Some people have had allergic reactions to Trikafta. They can sometimes be very serious. Signs can include swelling of the face or lips, tight feeling in the throat, and trouble breathing. Other signs of anaphylaxis are possible as well. If this happens, get medical help right away.
Trikafta can interact with other medications. These drug interactions can change the amount of Trikafta in your body. This affects how well it works and the risk of side effects. Trikafta can affect some medications as well.
Some medications, like carbamazepine (Tegretol) and St. John's wort, can lower the amount of Trikafta in your body. This can make Trikafta work less well. Other medications, like amiodarone (Pacerone) and clarithromycin, can raise Trikafta levels. This can put you at risk of side effects.
Tell your CF specialist and pharmacist about all the medications and supplements you take or plan to take. Also let them know if you change the way to take any of your medications. They can help make sure everything is safe and adjust doses if needed.
Risk factors: Taking steroids | Exposure to radiation
Some children who took ivacaftor, one of the medications in Trikafta, got cataracts. Some had other risk factors, like taking steroids or getting exposed to radiation. It's recommended for your child to get an eye exam before starting Trikafta. They should also have regular eye check-ups while taking the medication.
Your CF specialist will find the dose for you based on your body weight and age. Trikafta comes as prepackaged blister cards with the exact doses you need.
In general, you have a morning dose and an evening dose that you take about 12 hours apart. Take the medication with a high-fat meal or snack.
People 12 years and older
Morning dose: Each morning tablet contains elexacaftor 100 mg, tezacaftor 50 mg, and ivacaftor 75 mg. The typical dose is 2 morning tablets by mouth every morning.
Evening dose: Each evening tablet contains ivacaftor 150 mg. The typical dose is 1 evening tablet by mouth every night.
Children ages 6 to less than 12 years old
Weighing 66 lbs or more: Follow the dosing for people 12 years and older.
Weighing less than 66 lbs:
Morning dose: Each morning tablet contains elexacaftor 50 mg, tezacaftor 25 mg, and ivacaftor 37.5 mg. The typical dose is 2 morning tablets by mouth every morning.
Evening dose: Each evening tablet contains ivacaftor 75 mg. The typical dose is 1 evening tablet by mouth every night.
Children ages 2 to less than 6 years old (use the oral granule packets)
Weighing 31 lbs or more:
Morning dose: Each morning packet contains elexacaftor 100 mg, tezacaftor 50 mg, and ivacaftor 75 mg. The typical dose is 1 morning packet of granules every morning. Dissolve the granules with 1 teaspoon of soft food and then take by mouth.
Evening dose: Each evening packet contains ivacaftor 75 mg. The typical dose is 1 evening packet of granules every night. Dissolve the granules with 1 teaspoon of soft food and then take by mouth.
Weighing less than 31 lbs:
Morning dose: Each morning packet contains elexacaftor 80 mg, tezacaftor 40 mg, and ivacaftor 60 mg. The typical dose is 1 morning packet of granules every morning. Dissolve the granules with 1 teaspoon of soft food and then take by mouth.
Evening dose: Each evening packet contains ivacaftor 59.5 mg. The typical dose is 1 evening packet of granules every night. Dissolve the granules with 1 teaspoon of soft food and then take by mouth.
Your dose might be different depending on the other medications you take. It also might be different if you have liver problems.
Cystic fibrosis (CF) in people 2 years and older with specific mutations
By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.
American Lung Association. (2024). Treating and managing cystic fibrosis.
Cystic Fibrosis Foundation. (n.d.). Basics of the CFTR protein.
Gur, M., et al. (2023). Effect of Trikafta on bone density, body composition and exercise capacity in CF: A pilot study. Pediatric Pulmonology.
Guta M. T., et al. (2021). Global burden of anxiety and depression among cystic fibrosis patient: Systematic review and meta-analysis. International Journal of Chronic Diseases.
Hudson, B. N., et al. (2022). Drug-induced acne with elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis. Journal of Cystic Fibrosis.
Lopez, A., et al. (2023). Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del. Journal of Cystic Fibrosis.
Middleton, P. G., et al. (2020). Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a single Phe508del allele. The New England Journal of Medicine.
National Heart, Blood, and Lung Institute. (2024). Cystic fibrosis: Symptoms.
National Heart, Blood, and Lung Institute. (2024). Cystic fibrosis: Treatment.
Piehler, L., et al. (2023). Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis. Frontiers in Pharmacology.
Soltman, S., et al. (2021). Body composition in individuals with cystic fibrosis. Journal of Clinical & Translational Endocrinology.
Spoletini, G., et al. (2022). Dose adjustments of elexacaftor/tezacaftor/ivacaftor in response to mental health side effects in adults with cystic fibrosis. Journal of Cystic Fibrosis.
Vertex Pharmaceuticals Incorporated. (n.d.). Who Trikafta® is for?
Vertex Pharmaceuticals Incorporated. (n.d.). How to take Trikafta®.
Vertex Pharmaceuticals Incorporated. (n.d.). Looking for fat-containing food ideas?
Vertex Pharmaceuticals Incorporated. (2025). Trikafta- elexacaftor, tezacaftor, and ivacaftor kit [package insert]. DailyMed.
Zaher, A., et al. (2021). A review of Trikafta: Triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy. Cureus.
Zhang, L., et al. (2022). Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis. Therapeutic Advances in Respiratory Disease.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.